Bio

Bob joined LifeSci Capital in 2018 as a member of the investment banking team, where he advises on both public and private capital markets and M&A transactions for biotech, medtech, healthcare services and healthcare technology companies. Bob was also the Vice President of LifeSci Acquisition and LifeSci Acquisition II, where he assisted in identifying strong targets to acquire into LifeSci’s special purpose acquisition companies. Prior to joining LifeSci, Bob spent his time at Maxim Group in their investment banking division. Bob graduated from Pace University and received a BBA with majors in Finance and Mathematics. Bob holds the Series 63 and 79.